The STOP-MED CTRCD Trial

The STOP-MED CTRCD Trial

Conditions: Heart Failure; Cardiotoxicity; Cardiac Toxicity; Antineoplastics Toxicity; Cancer
Interventions: Other: Stopping Heart Failure Medication(s)
Sponsors: University Health Network, Toronto; Unity Health Toronto; Hamilton Health Sciences Corporation; St. Boniface Hospital; University of Alberta; University of Ottawa Heart Institute, Canada; University College London Hospitals; Alberta Health Services, Calgary; Brigham and Women’s Hospital; Baker Heart and Diabetes Institute
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 28, 2023Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments